Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease.
Inflammatory bowel disease is associated with extra-intestinal manifestations which occur either at the same time as flares of bowel inflammation (skin and eye disease) or run a course that is independent to inflammation in the bowel (liver and some joint syndromes). It has been suggested that the skin and eye complications occur as a consequence of the recruitment of activated effector cells released from the gut into the circulation to extra-intestinal site where they cause acute damage. However, this does not explain how patients can develop primary sclerosing cholangitis many years after having their colon removed for colitis. We propose that long-lived populations of memory lymphocytes arise as a consequence of bowel inflammation and that these cells express homing receptors that direct their subsequent migration not only to the gut but also to the liver. These long-lived cells may recirculate to the liver for many years and, in the absence of a local activating stimulus, will not cause damage. However, if they are subsequently activated in the liver this will lead to the development of inflammation and tissue damage which promotes the recruitment of more mucosal lymphocytes resulting in persistent inflammation and disease. The recent findings that MAdCAM-1 and CCL25, previously thought to be restricted to the gut, are up-regulated in the liver during inflammatory liver diseases that complicate IBD support the concept that common mechanisms control lymphocyte recruitment to the inflamed liver and gut.
Eksteen
Bertus
B
Liver Research Laboratories, MRC Centre for Immune Regulation, University of Birmingham, Queen Elizabeth Hospital, Birmingham.
Miles
Alice E
AE
Grant
Allister J
AJ
Adams
David H
DH
D002465:Cell Movement / Q000502:physiology*; D015209:Cholangitis, Sclerosing / Q000209:etiology* / Q000503:physiopathology; D006505:Hepatitis / Q000209:etiology* / Q000503:physiopathology; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000503:physiopathology*; D007413:Intestinal Mucosa / Q000503:physiopathology; D016201:Receptors, Lymphocyte Homing / Q000502:physiology*
D016201:Receptors, Lymphocyte Homing